Molecular Response to Imatinib and Its Correlation with mRNA Expression Levels of Imatinib Influx Transporter (OCT1) in Indian Chronic Myeloid Leukemia Patients

about

Molecular Response to Imatinib and Its Correlation with mRNA Expression Levels of Imatinib Influx Transporter (OCT1) in Indian Chronic Myeloid Leukemia Patients

Item

http://www.wikidata.org/entity/Q47117554

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Molecular Response to Imatinib ...... onic Myeloid Leukemia Patients

@en

Molecular Response to Imatinib ...... of Imatinib Influx Transporter

@nl

type

Item

label

Molecular Response to Imatinib ...... onic Myeloid Leukemia Patients

@en

Molecular Response to Imatinib ...... of Imatinib Influx Transporter

@nl

prefLabel

Molecular Response to Imatinib ...... onic Myeloid Leukemia Patients

@en

Molecular Response to Imatinib ...... of Imatinib Influx Transporter

@nl

P1476

Molecular Response to Imatinib ...... onic Myeloid Leukemia Patients

@en

P2093

K Singh

http://www.w3.org/2001/XMLSchema#string

M Mahapatra

http://www.w3.org/2001/XMLSchema#string

P Mishra

http://www.w3.org/2001/XMLSchema#string

R Chaubey

http://www.w3.org/2001/XMLSchema#string

R Saxena

http://www.w3.org/2001/XMLSchema#string

R Sharma

http://www.w3.org/2001/XMLSchema#string

S Chhikara

http://www.w3.org/2001/XMLSchema#string

S Sazawal

http://www.w3.org/2001/XMLSchema#string

T Seth

http://www.w3.org/2001/XMLSchema#string

P2860

Structural mechanism for STI-571 inhibition of abelson tyrosine kinase

Predictors of primary imatinib resistance in chronic myelogenous leukemia are distinct from those in secondary imatinib resistance.

Active transport of imatinib into and out of cells: implications for drug resistance.

OCT-1, ABCB1, and ABCG2 Expression in Imatinib-Resistant Chronic Myeloid Leukemia Treated with Dasatinib or Nilotinib.

Chronic Myeloid Leukaemia in The 21st Century.

Molecular biology of bcr-abl1-positive chronic myeloid leukemia.

Cellular uptake of imatinib into leukemic cells is independent of human organic cation transporter 1 (OCT1).

Targeted treatment of imatinib-resistant chronic myeloid leukemia: Focus on dasatinib.

The hOCT1 SNPs M420del and M408V alter imatinib uptake and M420del modifies clinical outcome in imatinib-treated chronic myeloid leukemia.

Interaction of imatinib with human organic ion carriers.

P304

2043-2048

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.22034/APJCP.2017.18.8.2043

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-08-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28843219

http://www.w3.org/2001/XMLSchema#string

P921

chronic myeloid leukemia

P932

5697457

http://www.w3.org/2001/XMLSchema#string